Wednesday, April 1, 2026

U.S. and Korean Military Crackdown on Drugs With Random Drug Tests

Active-duty soldiers will soon undergo annual random...

THE GATES of Hell Open: Seoul Deploys Mechanized Corps To North-Facing Province—Is This The Final Warning?

The U.S. Army's 7th Mechanized Corps will conduct live-fire exercises in Gyeonggi, Gangwon, and Chungbuk from Nov 19-26, impacting traffic.

Unlocking Secrets of North Korea: A Language and Culture Forum You Can’t Miss

South Korea’s 2nd Inter-Korean Cultural Exchange Forum on September 10 will explore North-South Korean language and cultural differences.

Tag: CGBIO

CGBio Reports Return to Operating Profit in 2025… Growth in Bone Substitutes and Dental Business

CGBio Co., Ltd. reported a $2.6M operating profit in 2025, reversing losses and achieving 36% revenue growth, driven by bone substitutes.

CGBio’s NovoFactory: A Game-Changer for Bone Graft Products in the U.S. and Japan

CGBio's new Novo Factory in Hwaseong receives approval to produce Novosis Putty, targeting advanced markets like the U.S. and Japan.

What Makes DOOTH the Game-Changer in Absorbable Sutures? Discover Its Unique Advantages!

CGBio is expanding its aesthetic business by exporting the absorbable suture DOOTH to Japan, aiming for global recognition and regulatory approvals.

K-Spine Surgery: How a Korean Firm Showcased Minimally Invasive Techniques at U.S. Conference

CGBIO successfully held a symposium on minimally invasive spinal surgery, enhancing skills of over 100 global professionals through hands-on training.

IMCAS 2026: Discover How Sijibio Secured Over 70.4 Million USD in Global Contracts

CGBIO showcased its collagen stimulator at IMCAS 2026, securing contracts worth 101.5 billion KRW to strengthen its global market position.

Top News

- Our Sponsors Ad -

Follow us